The Journal of Heart and Lung Transplantation
Volume 26, Issue 2 , Pages 174-180 , February 2007

Intragraft DPP IV Inhibition Attenuates Post-transplant Pulmonary Ischemia/Reperfusion Injury After Extended Ischemia

  • Wei Zhai, MD

      Affiliations

    • Department of Thoracic Surgery, University Hospital Zurich, Zurich, Switzerland
    • Department of Thoracic Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Huazhong, China
    • ,
  • Markus Cardell, MD

      Affiliations

    • Department of Thoracic Surgery, University Hospital Zurich, Zurich, Switzerland
    • ,
  • Ingrid De Meester, PhD

      Affiliations

    • Department of Pharmaceutical Sciences, University of Antwerp, Antwerp, Belgium.
    • ,
  • Koen Augustyns, PhD

      Affiliations

    • Department of Pharmaceutical Sciences, University of Antwerp, Antwerp, Belgium.
    • ,
  • Sven Hillinger, MD

      Affiliations

    • Department of Thoracic Surgery, University Hospital Zurich, Zurich, Switzerland
    • ,
  • Ilhan Inci, MD

      Affiliations

    • Department of Thoracic Surgery, University Hospital Zurich, Zurich, Switzerland
    • ,
  • Stephan Arni, PhD

      Affiliations

    • Department of Thoracic Surgery, University Hospital Zurich, Zurich, Switzerland
    • ,
  • Wolfgang Jungraithmayr, MD

      Affiliations

    • Department of Thoracic Surgery, University Hospital Zurich, Zurich, Switzerland
    • ,
  • Simon Scharpé, PhD

      Affiliations

    • Department of Pharmaceutical Sciences, University of Antwerp, Antwerp, Belgium.
    • ,
  • Walter Weder, MD

      Affiliations

    • Department of Thoracic Surgery, University Hospital Zurich, Zurich, Switzerland
    • ,
  • Stephan Korom, MD

      Affiliations

    • Department of Thoracic Surgery, University Hospital Zurich, Zurich, Switzerland
    • Corresponding Author InformationReprint requests: Stephan Korom, MD, Department of Thoracic Surgery, University Hospital Zurich, Raemistrasse 100, 8091 Zurich, Switzerland. Telephone: +41-1-255-8802. Fax: +41-1-255-8805.

Received 21 June 2006 ,Revised 9 October 2006 ,Accepted 21 November 2006.

References 

  1. Trulock EP, Edwards LB, Taylor DO, Boucek MM, Keck BM, Hertz MI. Registry of the International Society for Heart and Lung Transplantation: twenty-second official adult lung and heart–lung transplant report—2005. J Heart Lung Transplant. 2005;24:956–967
  2. Ambrosio G, Tritto I. Reperfusion injury: experimental evidence and clinical implications. Am Heart J. 1999;138:69–75
  3. De Perrot M, Liu M, Waddell TK, Keshavjee S. Ischemia–reperfusion-induced lung injury. Am J Respir Crit Care Med. 2003;167:490–511
  4. Lambeir AM, Durinx C, Scharpe S, De Meester I. Dipeptidyl-peptidase IV from bench to bedside: an update on structural properties, functions, and clinical aspects of the enzyme DPP IV. Crit Rev Clin Lab Sci. 2003;40:209–294
  5. Jung FJ, Yang L, De Meester I, Augustyns K, et al. CD26/Dipeptidylpeptidase IV–targeted therapy of acute lung rejection in rats. J Heart Lung Transplant. 2006;25:1109–1116
  6. Mizuta T, Kawaguchi A, Nakahara K, Kawashima Y. Simplified rat lung transplantation using a cuff technique. J Thorac Cardiovasc Surg. 1989;97:578–581
  7. De Meester I, Callewaert N, Lambeir AM, et al. In vitro effect of irreversible dipeptidyl peptidase IV inhibitors of the diaryl phosphonate type on the expression of their target molecule CD26 on the surface of human lymphocytes. Scand J Immunol. 2001;54(suppl 1):114
  8. Belyaev A, Zhang X, Augustyns K, et al. Structure–activity relationship of diaryl phosphonate esters as potent irreversible dipeptidyl peptidase IV inhibitors. J Med Chem. 1999;43:1041–1052
  9. Korom S, De Meester I, Stadlbauer TH, et al. Inhibition of CD26/DPPIV activity in vivo prolongs cardiac allograft survival in rat recipients. Transplantation. 1997;63:1495–1500
  10. Maes MB, Lambeir AM, Gilany K, et al. Kinetic Investigation of human dipeptidyl peptidase II mediated hydrolysis of dipeptide derivatives and its identification as quiescent cell proline dipeptidase/dipeptidyl peptidase 7. Biochem J. 2005;386:315–324
  11. Van Sande M, Scharpé S, Neels H, van Camp K. Distribution of angiotensin converting enzyme in human tissues. Clin Chim Acta. 1985;147:255–260
  12. Groneberg DA, Quarcoo D, Frossard N, Fischer A. Neurogenic mechanisms in bronchial inflammatory diseases. Allergy. 2004;59:1139–1152
  13. Said SI, Mutt V. Polypeptide with broad biological activity: isolation from small intestine. Science. 1970;169:1217–1218
  14. Ghatei MA, Sheppard MN, O Shaughnessy DJ, et al. Regulatory peptides in the mammalian respiratory tract. Endocrinology. 1982;111:1248–1254
  15. Delgado M, Pozo D, Ganea D. The significance of vasoactive intestinal peptide in immunomodulation. Pharmacol Rev. 2004;56:249–290
  16. Delgado M, Abat C, Martinez MG, et al. Vasoactive intestinal peptide in the immune system: potential therapeutic role in inflammatory and autoimmune diseases. J Mol Med. 2002;80:16–24
  17. Delgado M, Munoz-Elias EJ, Martinez C, Gomariz RP, Ganea D. VIP and PACAP38 mudulate cytokine and nitric oxide production in peritoneal macrophages and macrophage cell lines. Ann NY Acad Sci. 1999;897:401–414
  18. Nagahiro I, Yano M, Boasquevisque CH, Fujino S, Cooper JD, Patterson GA. Vasoactive intestinal peptide ameliorates reperfusion injury in rat lung transplantation. J Heart Lung Transplant. 1998;17:617–621
  19. Lambeir AM, Durinx C, Proost P, Damme JV, Scharpe S, De Meester I. Kinetic study of the processing by dipeptidyl-peptidase IV/CD26 of neuropeptides involved in pancreatic insulin secretion. FEBS Lett. 2001;507:327–330
  20. Mentlein R, Gallwitz B, Schmidt WE. Dipeptidyl-peptidase IV hydrolyses gastric inhibitory polypeptide, glucagon-like peptide-1(7–36)amide, peptide histidine methionine and is responsible for their degradation in human serum. Eur J Biochem. 1993;214:829–835
  21. Demuth HU, McIntosh CH, Pederson RA. Type 2 diabetes—therapy with dipeptidyl peptidase IV inhibitors. Biochim Biophys Acta. 2005;1751:33–34
  22. Zukowska-Grojec Z, Karwatowska-Prokopczuk E, Rose W, Rone J, Movafagh S, Ji H. Neuropeptide Y: a novel angiogenic factor from the sympathetic nerves and endothelium. Circ Res. 1998;83:187–195
  23. Ghersi G, Chen W, Lee EW, Zukowska Z. Critical role of dipeptidyl peptidase IV in neuropeptide Y-mediated endothelial cell migration in response to wounding. Peptides. 2001;24:453–458
  24. Zukowska-Grojec Z, Karwatowska-Prokopczuk E, Fisher TA, Ji H. Mechanisms of vascular growth-promoting effects of neuropeptide Y: role of its inducible receptors. Regul Peptides. 1998;75:231–238

 Supported by a grants from the Swiss National Foundation (SNF3200-65424) and the Fund for Scientific Research Flanders (G.0410.05).

PII: S1053-2498(06)01442-2

doi: 10.1016/j.healun.2006.11.601

The Journal of Heart and Lung Transplantation
Volume 26, Issue 2 , Pages 174-180 , February 2007

Article Tools

* Image Usage & Resolution